Evidence map›Paper›PMID 40133804›Full record

ArticleBMC nephrology2025

Acute oxalate nephropathy due to yellow rice wine: a case report.

Xi Chen, Jie Shen, Yuxue Liu, Yingchun Ran, Mindong Chen, Rong Zhou

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xi ChenDepartment of Nephrology, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, 200090, China.
Jie ShenDepartment of Nephrology, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, 200090, China.
Yuxue LiuDepartment of Nephrology, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, 200090, China.
Yingchun RanDepartment of Nephrology, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, 200090, China.
Mindong ChenDepartment of Nephrology, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, 200090, China.
Rong ZhouDepartment of Nephrology, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, 200090, China. zhourongyp@126.com.

Funding

Shanghai Yangpu District Key Medical Disciplines Scientific Research Fund, China 22YPZA02
6 · The paper itself

Abstract

backgroundAcute oxalate nephropathy is a rare but potentially underrecognized cause of acute kidney injury (AKI). The reports of secondary oxalate nephropathy induced by high doses of vitamin C, portulaca oleracea, Peanut were described, but the cause as yellow wine consumption are rare. We report a 63-year-old man with acute kidney injury due to yellow rice wine. The patient has drunk yellow rice wine 500 mL/day for the past 10 years. He underwent an ultrasound-guided renal biopsy, which showed acute tubular injury and birefringent crystals were observed in the renal tubules under a polarizing microscope. The 24-hour urinary oxalate excretion established and the baseline serum creatinine of 407 µmol/L. Following 3 months therapy, subsequent laboratory evaluation demonstrated significant reduction in urinary oxalate excretion excretion and serum creatinine normal.

conclusionsAcute secondary oxalate nephropathy due to excessive dietary intake of oxalate may lead to AKI. Kidney biopsies in unknown cause AKI patients is important and attention should be payed to food behaviors when reasons for AKI are explored.

Indexed as

Acute Kidney InjuryOryzaOxalatesWineHumansMaleMiddle AgedOxalatesAKIOxalate nephropathyYellow rice wine

Identifiers

PMID40133804
PMCPMC11934763

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.